Moneycontrol PRO
Outskill Genai
HomeNewsBusinessIPOAnupam Rasayan IPO day 2: Issue subscribed 3.64 times, HNI portion fully booked

Anupam Rasayan IPO day 2: Issue subscribed 3.64 times, HNI portion fully booked

"Though the valuations looks expensive on P/E multiple, we expect these to moderate in future on account of lower finance cost in future as the issue proceeds will be utilised for debt reduction," Chola Securities said.

March 15, 2021 / 17:19 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The Rs 760-crore public offer of Anupam Rasayan has, so far, been subscribed 3.64 times on the second day of bidding, March 15. The offer has received bids for 3.53 crore equity shares against the IPO size of over 97 lakh equity shares, the subscription data available on exchanges showed.

    The retail investors are lending support to the issue as the reserved portion for them has been oversubscribed by 6.60 times, while employees' portion has been booked 93 percent.

    The portion set aside for non-institutional investors has seen a subscription of 1.39 times, and that of qualified institutional buyers 37 percent.

    Also read: Anupam Rasayan IPO: Top 10 things to know before subscribing to the issue

    The public issue, which is fully a fresh issue of Rs 760 crore, opened for bidding on March 12 and will close on March 16. The price band was set at Rs 553-555 per share. The funds will be utilised for repayment of debts.

    Anupam Rasayan is custom synthesis and manufacturer of specialty chemicals, primarily focused on agrochemicals. The company has two distinct business verticals - Life sciences specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising of specialty pigment, dyes, and polymer additives. The company competes with leading players like PI Industries and Aarti Industries.

    Also read: Anupam Rasayan IPO opens for bidding: Should you subscribe?

    "The IPO is valued at 80x and 69x EPS for FY20 and annualized FY21, respectively. Though the valuations looks expensive on P/E multiple, we expect these to moderate in future on account of lower finance cost in future as the issue proceeds will be utilised for debt reduction," Chola Securities said.

    "The company has strong and long-term relationships with various multinational corporations (MNCs), including, Syngenta Asia Pacific, Sumitomo Chemical and UPL, which has helped it expand product offerings and geographic reach across Europe, Japan, United States and India," added the brokerage which advised subscribing the issue for a long term.

    Also readAnupam Rasayan IPO: Aggressively priced at 74x P/E for FY21, is it worth subscribing?

    Also readCraftsman Automation IPO opens today: Should you subscribe?

    Moneycontrol News
    first published: Mar 15, 2021 12:40 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347